ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy | March 31, 2021
ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses
March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced...
read more
Diagnostic imaging studies using Tc-99m inform healthcare decisions for approximately 30 million patients annually around the world
News | Nuclear Imaging | March 08, 2021
IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m
March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a...
read more
Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Feature | Treatment Planning | March 05, 2021 | By Melinda Taschetta-Millane
Using PET to Enhance Prostate Treatment Planning
The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and...
read more
ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.
News | Stereotactic Body Radiation Therapy (SBRT) | February 12, 2021
ZAP Surgical Builds Market for its Novel ZAP-X Gyroscopic Radiosurgery Platform
February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized...
read more
Sponsored Content | Sponsored Content | Videos | Information Technology | December 01, 2020
Talking Trends with Elekta
Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements...
read more
Mary C. Mahoney, M.D.

Mary C. Mahoney, M.D.

News | RSNA | December 01, 2020
Mary C. Mahoney, MD, Named RSNA President
December 1, 2020 — At the Virtual RSNA 2020 conference, it was announced that Mary C. Mahoney, M.D., is RSNA president...
read more
Radiation oncologists across the country will meet virtually with members of Congress this week to discuss value-based payment, prior authorization and supporting cancer care during the pandemic

Getty Images

News | Radiation Oncology | November 18, 2020
Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic
November 18, 2020 — Radiation oncologists across the country will meet virtually with members of Congress this week to...
read more
Metastasis-free survival is a strong surrogate endpoint for overall survival over biochemical failure for men receiving salvage radiotherapy for recurrent prostate cancer

Getty Images

News | Prostate Cancer | November 02, 2020
MFS Is a Strong Surrogate Endpoint for OS for Men Receiving Salvage RT
November 2, 2020 — An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage...
read more
Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

News | Radiation Therapy | November 02, 2020
Some Rectal Cancer Patients Can Safely Avoid an Aggressive Operation
November 2, 2020 — A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for...
read more
Innovation can help address screening backlog due to COVID-19 pandemic by streamlining breast imaging reading process
News | Breast Imaging | November 02, 2020
Hologic Launches 3DQuorum Imaging Technology, Powered by Genius AI, in Europe
November 2, 2020 — Hologic, Inc. announced the commercial availability in Europe of its 3DQuorum Imaging Technology,...
read more
Updated results of NRG Oncology trial display effectiveness of gemcitabine and daily radiation for bladder preservation in muscle-invasive bladder cancer patients
News | Radiation Oncology | November 02, 2020
Effectiveness of Gemcitabine and Daily RT for Bladder Preservation in Muscle-invasive Bladder Cancer
November 2, 2020 — Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy...
read more
Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer | October 30, 2020
Outcomes of Salvage Low Dose RT Brachytherapy After EBRT for Prostate Cancer
October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR)...
read more
Vinai Gondi, M.D., the Director of Research at the Northwestern Medicine Chicago Proton Center, Co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

Vinai Gondi, M.D., director of research at the Northwestern Medicine Chicago Proton Center, co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

News | Intensity Modulated Radiation Therapy (IMRT) | October 27, 2020
Photon IMRT Treatment Group Displays No Significant Survival Difference Between Arms
October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical...
read more
"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial" was presented by Jing Li, M.D., The University of Texas MD Anderson Cancer Center, at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
Radiosurgery Reduces Cognitive Decline Without Compromising Survival for Patients with 4+ Brain Metastases
October 26, 2020 — Results of a new randomized phase III trial suggest that stereotactic radiosurgery (SRS) should...
read more
"Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Shankar Siva, Ph.D., Peter MacCallum Cancer Centre, was presented at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
Group Trial Bolsters Case for Stereotactic Radiation Therapy for Tumors that Travel to the Lungs
October 26, 2020 — A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the case...
read more
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
Adding Advanced PET Scans to Radiation Treatment Plans for Prostate Cancer Increases Failure-free Survival Rates
October 26, 2020 — Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation...
read more
A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases was presented by Arjun Sahgal, M.D., University of Toronto, today at ASTRO20
News | Radiation Therapy | October 26, 2020
Treating Spinal Metastases with Fewer and Higher Doses of Radiation Reduces Pain More Effectively
October 26, 2020 — A new study shows using fewer and higher doses of high-precision radiation therapy is a more...
read more
iCAD showcasing expanded Xoft Platform including Single-Fraction IORT Solution for brain and early-stage breast cancer tumors
News | Brachytherapy Systems | October 26, 2020
New Research Presented at ASTRO20 Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers
October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic...
read more
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will be...
read more
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
Proton Therapy for Lung Cancer May Help Reduce Risk of Heart Diseases
October 25, 2020 — Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced...
read more
© Copyright Wainscot Media. All Rights Reserved.